Adults aged 18 years or older with a diagnosis of atopic dermatitis for 12 months or more and a weight of 50 to 180 kg are needed for this clinical research trial. Eligible participants must have moderate to severe disease with plaques covering 10% or more of the body surface area (BSA).
Participants will receive investigational doses of treatment (active study drug) or placebo, via an injection form. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 41 weeks and involve about 11 visits to the study center.
The following information is from ClinicalTrials.gov
Last Update Posted: March 21, 2023
Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.